Extracellular matrix stiffness modulates the nuclear lamina organisations and set nuclear conditions for PRC2 repression.

Non programmé
20m
amphithéâtre (GENOPOLYS)

amphithéâtre

GENOPOLYS

Génopolys - Campus Arnaud de Villeneu, 34396, 141 Rue de la Cardonille, 34090 Montpellier

Orateur

Dr Cyril Esnault (Institut de Génétique Moléculaire de Montpellier (IGMM))

Description

Although the cells of a multicellular organism share the same genetic material, their functions, structures, and behaviours can vary significantly. Many of these differences arise from distinct gene expression programs. Environmental cues are integrated and mediate epigenetic changes that regulate cell activity, differentiation and development. Cells sense their microenvironment not only through soluble signals but also through mechanical cues. The responsiveness to tissue-level elasticity has important physiological and pathological implications. For instance, stiffening of the extracellular matrix promotes the invasive behaviour of cancer cells, supports the transformation of fibroblasts into cancer-associated fibroblasts (CAFs), prime mesenchymal stem cell (MSC) differentiation programs, and regulate epidermal stem cell fate. By combining hydrogel cell culturing, genomics and super-resolution microscopy, we found that extracellular matrix stiffness modulates the nuclear lamina composition and induces variation in chromatin motion. Furthermore, adaptative gene programs are in part controlled through Polycomb Repressive Complex 2 (PRC2) repression which is tempered by mechano-transduction and the nuclear lamina. Our work highlights mechano-dependent nuclear lamina compositions and changes in chromatin motions that set adaptative gene expression program control through PRC2.

Authors

Dr Alexia Pigeot (Institut de Génétique Moléculaire de Montpellier (IGMM)) Dr Martin Rey-Millet Dr Amal Zine El Aabidine (Institut de Génétique Moléculaire de Montpellier (IGMM)) Dr Antonio Trullo (Institut de Génétique Moléculaire de Montpellier (IGMM)) Kerstin Bystricky (CBI) Dr Jean-Christophe Andrau (Institut de Génétique Moléculaire de Montpellier (IGMM)) Dr Cyril Esnault (Institut de Génétique Moléculaire de Montpellier (IGMM))

Documents de présentation